9 Meters Biopharma NMTR

Quarterly report 2023-Q1
added 05-15-2023

9 Meters Biopharma DIO Ratio 2011-2026 | NMTR

Annual DIO Ratio 9 Meters Biopharma

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	18.9	121	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
121	18.9	70

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Amgen AMGN	200	$ 340.0	-0.75 %	$ 183 B	USA
	Amneal Pharmaceuticals AMRX	117	$ 12.32	-0.24 %	$ 3.86 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Arcutis Biotherapeutics ARQT	185	$ 23.27	-1.63 %	$ 2.96 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.36	-2.16 %	$ 362 M	Britain
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Aytu BioScience AYTU	209	$ 2.57	-3.38 %	$ 16.1 M	USA
	Avid Bioservices CDMO	102	-	-	$ 789 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	CTI BioPharma Corp. CTIC	38.1	-	-	$ 1.2 B	USA
	Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
	Deciphera Pharmaceuticals DCPH	2.04 K	-	-	$ 2.18 B	USA
	Dynavax Technologies Corporation DVAX	455	-	-	$ 2.02 B	USA
	Dyadic International DYAI	161	$ 0.88	1.66 %	$ 31.8 M	USA
	Coherus BioSciences CHRS	97.5	$ 1.67	-	$ 196 M	USA